Xu Xian-Fa, Tang Ping-Zhang, Cheng Shu-Jun
Department of Otolaryngology- Head and Neck Surgery, Beijing Chaoyang Hospital, Capital University of Medical Sciences, Beijing, PR China.
Ai Zheng. 2003 May;22(5):452-7.
BACKGROUND & OBJECTIVE: Microsatellites are the repeated DNA sequences scattered widely within the biological genomes and closely linked with many important genes. In carcinogenesis, microsatellites often display loss of heterozygosity(LOH) as tumor suppressor genes. Some microsatellite loci often exist in the hot spots of LOH at high frequency in some specific maligances. The tumor suppressor genes, which are associated with the development and progression of the tumor, possibly harbor in the vicinity of these hot spots. Therefore, the study of LOH by microsatellite analysis is an important way to detect the putative tumor suppressor genes. This study was designed to refine the hot spots of LOH on 9p13-23 in laryngeal squamous cell carcinoma and compare the correlation between the incidence of microsatellite LOH and the clinicopathological parameters.
Tumor tissues were obtained from paraffin embedded sections with microdissection. Genomic DNA was extracted from tumor tissues and peripheral blood lymphocytes with the phenol-chloroform. Polymerase chain reaction(PCR) amplification and denaturing gel electrophoresis were performed on a set of 42 laryngeal squamous cell carcinoma and corresponding peripheral blood lymphocytes using 13 highly polymorphic microsatellite markers on 9p13-23. The correlation was analyzed between microsatellite LOH at the high frequency on 9p13-23 and clinicopathological characteristics in the patients with squamous cell carcinoma of larynx.
(1)Of the 42 laryngeal cancers, 41(97.6%) showed LOH in at least one of the microsatellite markers tested on 9p13-23. The most frequently deleted marker was D9S162 in 17 of the 19 (89.5%) informative samples. The marker D9S171, which is located on 9p21, had LOH detected in 12 of the 15 informative cases (80.0%). LOH at the D9S1748 marker (closest to the p16 gene locus) was detected in 18 of the 36 informative cases (50.0%). (2)Allelic deletion mapping revealed two minimal regions of LOH encompassing markers D9S161-D9S171 on 9p21 and IFNA-D9S162 on 9p22-23. (3) Multiple LOH (>or= 4) on 9p21-23 was found more frequently in the patients under 60 years, with supraglottic squamous cell carcinoma or cervical lymph node metastasis than those over 60 years, with glottic squamous cell carcinoma or without cervical lymph node metastasis (P< 0.01,P< 0.01,P< 0.05, respectively). On the contrary, there was no correlation between T stages or pathologic classification and the frequency of LOH on 9p21-23 in 42 squamous cell carcinoma of larynx.
These findings imply the presence of at least two putative tumor suppressor genes on 9p13-23 in laryngeal squamous cell carcinoma. Multiple genetic alterations are probably implicated in supraglottic squamous cell carcinoma with cervical lymph node metastasis in younger patients.
微卫星是广泛散布于生物基因组中的重复DNA序列,与许多重要基因紧密相连。在肿瘤发生过程中,微卫星常作为肿瘤抑制基因出现杂合性缺失(LOH)。一些微卫星位点在某些特定恶性肿瘤中常高频存在于LOH热点区域。与肿瘤发生发展相关的肿瘤抑制基因可能存在于这些热点区域附近。因此,通过微卫星分析研究LOH是检测潜在肿瘤抑制基因的重要方法。本研究旨在明确喉鳞状细胞癌9p13 - 23区域LOH的热点区域,并比较微卫星LOH发生率与临床病理参数之间的相关性。
通过显微切割从石蜡包埋切片中获取肿瘤组织。采用酚 - 氯仿法从肿瘤组织和外周血淋巴细胞中提取基因组DNA。使用9p13 - 23区域的13个高度多态性微卫星标记,对42例喉鳞状细胞癌及其相应外周血淋巴细胞进行聚合酶链反应(PCR)扩增和变性凝胶电泳。分析9p13 - 23区域高频微卫星LOH与喉鳞状细胞癌患者临床病理特征之间的相关性。
(1)在42例喉癌中,41例(97.6%)在9p13 - 23检测的至少一个微卫星标记中显示LOH。在19个有信息样本中的17个(89.5%)中,最常缺失的标记是D9S162。位于9p21的标记D9S171,在15个有信息病例中的12个(80.0%)中检测到LOH。在36个有信息病例中的18个(50.0%)中检测到最接近p16基因座的D9S1748标记的LOH。(2)等位基因缺失图谱显示两个最小LOH区域,分别包含9p21上的标记D9S161 - D9S171和9p22 - 23上的IFNA - D9S162。(3)9p21 - 23区域多个LOH(≥4个)在60岁以下、声门上鳞状细胞癌或有颈部淋巴结转移的患者中比60岁以上、声门鳞状细胞癌或无颈部淋巴结转移的患者更常见(分别为P < 0.01、P < 0.01、P < 0.05)。相反,在42例喉鳞状细胞癌中,T分期或病理分级与9p21 - 23区域LOH频率之间无相关性。
这些发现提示喉鳞状细胞癌9p13 - 23区域至少存在两个潜在的肿瘤抑制基因。年轻患者声门上鳞状细胞癌伴颈部淋巴结转移可能涉及多个基因改变。